Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Objectives: To provide guidance for the management of mood disorders, based on scientific
evidence supplemented by expert clinical consensus and formulate recommendations to …
evidence supplemented by expert clinical consensus and formulate recommendations to …
Treatment of bipolar disorder
We review recent developments in the acute and long-term treatment of bipolar disorder and
identify promising future routes to therapeutic innovation. Overall, advances in drug …
identify promising future routes to therapeutic innovation. Overall, advances in drug …
The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Objectives: To provide advice and guidance regarding the management of mood disorders,
derived from scientific evidence and supplemented by expert clinical consensus to formulate …
derived from scientific evidence and supplemented by expert clinical consensus to formulate …
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients …
The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …
Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology
The British Association for Psychopharmacology guidelines specify the scope and targets of
treatment for bipolar disorder. The third version is based explicitly on the available evidence …
treatment for bipolar disorder. The third version is based explicitly on the available evidence …
Psychopharmaka
MJ Lohse, J Seifert, S Bleich - Arzneiverordnungs-Report 2021, 2021 - Springer
Zusammenfassung Auf einen Blick Zusammenfassung Mit weit über 2 Milliarden DDD
stellen die Psychopharmaka eine der größten Arzneimittelgruppen dar. Dabei sind die seit …
stellen die Psychopharmaka eine der größten Arzneimittelgruppen dar. Dabei sind die seit …
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term …
Objectives. These guidelines are based on a first edition that was published in 2004, and
have been edited and updated with the available scientific evidence up to October 2012 …
have been edited and updated with the available scientific evidence up to October 2012 …
Bipolar disorder
IM Anderson, PM Haddad, J Scott - Bmj, 2012 - bmj.com
A recent worldwide survey in 11 countries found a median age of onset of about 25 years, 3
with an overall lifetime prevalence of 0.6% for bipolar I disorder (male predominance …
with an overall lifetime prevalence of 0.6% for bipolar I disorder (male predominance …
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
OBJECTIVE: Little is known about clinical features associated with the risk of recurrence in
patients with bipolar disorder receiving treatment according to contemporary practice …
patients with bipolar disorder receiving treatment according to contemporary practice …
Sleep–wake disturbance in interepisode bipolar disorder and high-risk individuals: A systematic review and meta-analysis
Over the past decade, researchers have shifted focus from the manic and depressive
episodes to the interepisode period in the study of sleep–wake disturbance in bipolar …
episodes to the interepisode period in the study of sleep–wake disturbance in bipolar …